Molecular Diagnostics
Molecular Diagnostic Platform for Automated Sample Processing to Help Labs Achieve New Flexibility Level
QIAGEN N.V. (Venlo, Netherlands) has launched EZ2 Connect MDx for use in diagnostic laboratories, making the IVD platform for automated sample processing available for wide scale use 18 months after it was first made available for research. The EZ2 Connect MDx offers a high degree of automation, enabling labs to purify DNA and RNA from 24 samples in parallel in as less as 30 minutes. More...23 Jan 2023
Early Alzheimer’s Detection Sensor Could Also Diagnose Other Diseases at POC 
Currently, screening tests for Alzheimer’s disease involve a questionnaire to determine the individual’s symptoms, brain imaging, or a spinal tap process to test for biomarker proteins in the cerebral spinal fluid. Now, researchers are developing a new biosensor for detecting tumor Necrosis Factor alpha (TNF alpha) that can be used to screen for Alzheimer’s disease and other diseases. More...
23 Jan 2023
First-Of-A-Kind Pan-Cancer Blood Test Could Predict Immunotherapy Efficacy and Toxicity
A first-of-a-kind pan-cancer blood test for the prediction of immunotherapy efficacy and toxicity could guide clinicians in patient selection to support the effective use of immune checkpoint inhibitors (ICI), thereby encouraging the use of ICIs in the earlier stages of cancer. More...20 Jan 2023
World’s First Test Detects Diabetics at Risk of Kidney Disease before Symptoms Appear
Researchers have identified the genetic markers for people with diabetes who are at a risk of developing kidney disease. This paves the way for the development of a test that could identify adults with Type 1 diabetes who are at a risk of kidney disease before they show any symptoms, enabling the introduction of early-stage interventions by doctors. More...19 Jan 2023
ELISAs Reliably Detect Anti-CCHFV Antibodies in Acute Infections
Crimean-Congo haemorrhagic fever (CCHF) is a life-threatening tick-borne viral disease included in the WHO priorities for research and product development for early diagnostics. EUROIMMUN (Lübeck, Germany), a PerkinElmer, Inc. (Waltham, MA; USA) company, has developed and subsequently evaluated ELISAs for the detection of specific IgM and IgG antibodies against the causative virus (CCHFV). More...19 Jan 2023
New Blood Test Tracks and Follows Neurodegeneration in Alzheimer's
A new blood test that specifically and selectively measures non-phosphorylated tau coming from the brain into the bloodstream meets an urgent unmet need for tracking neurodegenerative changes specifically in Alzheimer’s disease but not in other dementias. More...19 Jan 2023
Electrochemical Cell-Free Biosensor Directly Detects Influenza Antibodies in Blood at POC
Researchers have developed a new method for the rapid, inexpensive, yet quantitative and specific point-of-care detection of antibodies. The new method uses an electrochemical cell-free biosensor that can directly detect antibodies against diseases such as influenza in blood serum. More...18 Jan 2023
Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
In Other News
Highly Accurate Test "Fishes" For Respiratory Viruses Using DNA as Bait
Cheap, Easy Blood Test Detects Cancer by Identifying Broken DNA
Simple Blood Test Could Screen for Common and Dangerous Pregnancy Complications
Genetic Test Improves Ovarian Cancer Treatment
Blood Test Could Detect Alzheimer's 10 Years Before Symptoms Show
Blood Microbiome-Driven Liquid Biopsy Assay Detects Lung Cancer in Earliest Stages
BD, CerTest Announce Emergency Use Authorization for Mpox Diagnostic Test
New Database Provides First-Ever Map of Proteome Signature in Blood from Cancer Patients
Raman Spectroscopy Test Could Improve Lyme Disease Diagnostics
Rapid Diagnostic Test Uses Light to Detect Malaria without Blood Samples
First Blood Panel to Detect Deadly Placenta Accreta Spectrum
Amniotic Fluid Cells RNA-Sequencing Demonstrates Diagnostic Potential in Deciphering Rare Diseases
Single Immune System Molecule on Nasal Swabs Detects Stealthy Viruses Not Identified in Standard Tests
CRISPR Protein Could Yield New Tests for Many Viruses
Nanopore Sequencing Detect Pathogens in Knee Periprosthetic Joint Infection
Multi-Cancer Detection Blood Test to Enable Early Diagnosis and Treatment
Blood-Based Screening Test for Colorectal Cancer Demonstrates Strong Clinical Performance
Blood Test Helps Diagnose Inaccessible Brain Tumors
Clinical Microarray System Developed for Genetic Analysis Screening
First Leukemia Diagnostic Test Based on DNA Sequencing Detects up To 51 Gene Mutations
Biomarker Test Detects Alzheimer’s Neurodegeneration in Blood
Tuberculosis Pathogen Dynamics Detected With Nanopore Sequencing
Real-Time PCR-Based Serological Diagnosis of Human Granulocytic Anaplasmosis
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.